Literature DB >> 5017770

Metabolites of dihydrotachysterol in target tissues.

R B Hallick, H F DeLuca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5017770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  7 in total

1.  Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.

Authors:  P E Cordy
Journal:  Can Med Assoc J       Date:  1977-10-08       Impact factor: 8.262

2.  Rickets.

Authors: 
Journal:  West J Med       Date:  1976-09

3.  The treatment of hypoparathyroidism with 1alpha-hydroxycholecalciferol.

Authors:  D P Brenton; C E Dent; J M Gertner
Journal:  Calcif Tissue Res       Date:  1977-05

4.  Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.

Authors:  D von Herrath; K Schaefer; D Kraft; H G Grigoleit; P Koeppe
Journal:  Klin Wochenschr       Date:  1973-10-01

5.  Metabolism of dihydrotachysterol and 5,6-trans-cholecalciferol in the chick and the rat.

Authors:  D E Lawson; P A Bell
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

6.  Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3.

Authors:  M R Haussler; J E Zerwekh; R H Hesse; E Rizzardo; M M Pechet
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

7.  Dihydrotachysterol: a calcium active steroid not dependent upon kidney metabolism.

Authors:  H E Harrison; H C Harrison
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.